Atrophic Endometrium: Understanding Your Pathology Report

Section Editor: Kianoosh Keyhanian MD FRCPC
September 1, 2026

Atrophic endometrium describes a lining of the uterus that has become thin and inactive. The lining is called the endometrium. Pathologists use atrophy to describe tissue that shrinks and becomes less active, and here it happens because the lining is no longer stimulated by estrogen and progesterone.

This is a benign finding. It is not cancer, and it is not precancerous. After menopause, this is the expected appearance of the lining, and it can also be seen in younger people in certain situations. Your report may use the term inactive endometrium for the same finding.

If you had bleeding after menopause and this is your result, there is something important to know: a thin, atrophic lining is itself the most common cause of that bleeding. This article will help you understand what the term means on your pathology report and why it matters for your care.

What causes atrophic endometrium?

The lining of the uterus is built and maintained by estrogen and progesterone. When those hormones are absent or suppressed, the lining stops rebuilding each month and gradually thins. This is a normal response, not a disease.

Menopause — The most common reason by far. Once the ovaries stop producing estrogen, the lining becomes thin and stays that way.
The years around menopause — Hormone levels fluctuate and fall, and the lining may be atrophic in some cycles and not others.
Before puberty — The lining is inactive until the hormonal cycle begins.
Hormonal contraception — Combined pills, progestin-only pills, and hormonal IUDs all thin the lining. This is how several of them reduce bleeding, and it is an intended effect rather than a problem.
Medications that suppress the ovaries — Treatments used for endometriosis, fibroids, or breast cancer can produce the same picture. This is usually reversible when you stop the medication.
Loss of ovarian function at a younger age — Surgery to remove both ovaries, chemotherapy, radiation, or premature ovarian insufficiency all have this effect.

Because appearance depends so heavily on the medications you take, that information genuinely helps the pathologist. If you use a hormonal IUD or any hormone medication, it should be recorded on the requisition form that goes to the laboratory with your sample.

What are the symptoms?

Atrophic endometrium usually causes no symptoms and is simply the normal state of the lining after menopause. When it does cause symptoms, the most common symptom is bleeding.

A very thin lining is fragile. The surface can break down, and nearby small blood vessels can bleed, causing light bleeding or spotting. Endometrial atrophy is the single most common cause of bleeding after menopause, ahead of polyps, hormone therapy effects, and cancer.

Endometrial atrophy is not the same thing as vaginal atrophy, though the two often occur together and both are caused by low estrogen. Vaginal atrophy causes dryness, irritation, and discomfort with intercourse, and it can also cause light bleeding. It is treated, usually with vaginal estrogen, while endometrial atrophy on its own is not.

How is the diagnosis made?

A pathologist identifies atrophic endometrium by examining a sample of the lining under a microscope. The sample usually comes from an endometrial biopsy, a brief clinic procedure using a thin flexible tube, or from a dilation and curettage. It may also be found in a uterus removed at surgery.

Bleeding after menopause is always investigated, because roughly 1 in 10 people who have it turn out to have endometrial cancer. Evaluation usually involves both an ultrasound to measure the thickness of the lining and a tissue sample. Guidance on this changed in 2026. A thin ultrasound measurement is no longer considered sufficient on its own because it misses some cancers. Tissue sampling is now recommended as part of the initial evaluation.

One practical point comes up often. Because an atrophic lining is so thin, there is very little tissue to collect. Reports frequently describe the sample as scant, fragmented, or insufficient for evaluation. This is common and does not mean anything was done wrong. It does mean the sample may not have ruled out a small abnormality, so your doctor may want to look further.

What does atrophic endometrium look like under the microscope?

Atrophic endometrium is a thin lining of the uterus in which the glands are small and inactive, and there is little sign of growth. Under the microscope, the pathologist looks for the following features.

Small, flattened cells — The cells forming the glands are low and flat or cube-shaped rather than tall. The epithelium is a thin, quiet layer.
Very few dividing cells — Mitotic figures, which are cells caught in the act of dividing, are rare or absent. This reflects a lining that is not rebuilding.
Small or cystic glands — The endometrial glands are small and widely spaced. Some become rounded and dilated with fluid, which the report may describe as cystic atrophy. This is a normal variation and not a cyst in the ordinary sense.
Inactive supporting tissue — The stroma between the glands looks dense and fibrous rather than cellular and active.
Little tissue overall — Samples are often small, consisting of strips of surface lining rather than full-thickness tissue.

What does this result mean if I had bleeding after menopause?

For most people,e this is a reassuring result. The pathologist examined the tissue, found a thin, inactive lining, and found no hyperplasia or cancer. Atrophy is the usual explanation for bleeding at this stage of life, so the finding often answers the question rather than leaving it open.

Two things are worth understanding alongside that reassurance. First,t a biopsy samples part of the lining rather than all of it. A small abnormality such as a polyp can sit in an area that was not sampled. Second, a small number of endometrial cancers arise in a thin lining rather than a thickened one. A thin lining is not by itself proof that nothing is there.

The practical consequence is straightforward. If the bleeding stops, you usually don’t need further action. If the bleeding continues or returns, tell your doctor, because further evaluation is recommended regardless of how reassuring the first result was. This usually means a hysteroscopy, in which a camera is used to look directly at the lining.

How is this different from other descriptions of the endometrium?

Pathologists use several terms to describe the lining, and most describe normal states rather than diseases. Your report may use any of the following.

Atrophic or inactive endometrium — Thin and inactive. The expected finding after menopause.
Proliferative endometrium — Actively growing under the influence of estrogen. Proliferative endometrium is normal before menopause, but after menopause it means estrogen is reaching the lining from somewhere.
Secretory endometrium — Changed by progesterone after ovulation. Secretory endometrium is normal in the second half of a cycle.
Disordered proliferative endometrium — Irregular, unevenly spaced glands reflecting estrogen without progesterone. Disordered proliferative endometrium is not precancerous.
Endometrial hyperplasia — Crowded glands from prolonged estrogen stimulation. Endometrial hyperplasia is treated and followed.

What other findings may be described in the report?

Atrophic endometrium is often reported alongside other findings from the same sample.

Endometrial polyp — An endometrial polyp is a benign overgrowth of the lining and a common cause of bleeding after menopause. Polyps can be present in an otherwise atrophic lining.
Surface breakdown — Areas where the fragile surface has broken down, often the direct explanation for the bleeding.
Chronic inflammation — If plasma cells are present, the report may also diagnose chronic endometritis.
Negative for hyperplasia and malignancy — A standard phrase meaning the pathologist looked for crowded glands and for cancer and found neither.
Sample adequacy — A comment that the sample was scant or insufficient. Very common with a thin lining, and worth asking about if you are still bleeding.

What happens next?

Atrophic endometrium requires no treatment on its own. It is a normal state, not a condition that needs correcting. What happens next depends on your symptoms. Points your doctor may raise include:

If the bleeding has stopped — No further testing is usually needed, and no follow-up is required for the atrophy itself.
If the bleeding continues — Further evaluation is recommended, usually a hysteroscopy, since a small or focal abnormality may not have been captured in the sample.
Treating vaginal symptoms — Dryness, irritation, and discomfort with intercourse are treated with vaginal estrogen or non-hormonal moisturizers. These treat the vaginal tissue, not the lining of the uterus.
Reviewing medications — If a hormonal medication or IUD explains the finding, you may not need to change anything. Confirm this rather than assume.
Hormone therapy — If you are taking or considering it, your doctor can explain what it means for the lining and why a progestin is included when you still have a uterus.

Questions to ask your doctor

Does this result explain the bleeding I had?
Was the sample adequate, or was it too small to be fully reassuring?
Does my report say negative for hyperplasia and malignancy?
Did it report a polyp or any other finding?
Could my IUD or hormone medication explain this result?
Was an ultrasound done as well, and what did it show?
What should I do if the bleeding comes back?
Would a hysteroscopy be useful in my case?
Is my vaginal dryness or discomfort related, and can it be treated?
Is this finding expected for my age?
Do I need any follow-up or repeat testing?
What symptoms should prompt me to contact you?